These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22537729)

  • 1. Developmentally informed pharmacotherapy for child and adolescent depressive disorders.
    Sakolsky D; Birmaher B
    Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):313-25, viii. PubMed ID: 22537729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evidence for psychopharmacological treatment of depression in children and adolescents?].
    Thomsen PH; Sørensen MJ
    Ugeskr Laeger; 2007 Apr; 169(14):1289-94. PubMed ID: 17437688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of children and adolescents with depression.
    Vitiello B; Ordóñez AE
    Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for major depression in children and adolescents.
    Wagner KD
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):819-26. PubMed ID: 15908090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D; Zhang Z; Zhang X; Li L
    Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy in depressed children and adolescents.
    Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 15. Escitalopram for the treatment of major depressive disorder in youth.
    Ahn JH; Patkar AA
    Expert Opin Pharmacother; 2011 Oct; 12(14):2235-44. PubMed ID: 21895554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we use antidepressants for the treatment of major depressive disorder in children and adolescents?
    Birmaher B; Brent D
    Braz J Psychiatry; 2005 Jun; 27(2):89-90. PubMed ID: 15962128
    [No Abstract]   [Full Text] [Related]  

  • 17. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA; Laughren T; Racoosin J
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation treatment with antidepressants in child and adolescent major depression.
    Ryan ND
    Am J Psychiatry; 2008 Apr; 165(4):411-2. PubMed ID: 18381908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.